| Year |
Citation |
Score |
| 2024 |
Thomas CE, Georgeson P, Qu C, Steinfelder RS, Buchanan DD, Song M, Harrison TA, Um CY, Hullar MA, Jenkins MA, Van Guelpen B, Lynch BM, Melaku YA, Huyghe JR, Aglago EK, ... ... Giannakis M, et al. Epidemiologic factors in relation to colorectal cancer risk and survival by genotoxic colibactin mutational signature. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 38252034 DOI: 10.1158/1055-9965.EPI-23-0600 |
0.342 |
|
| 2023 |
Zhao M, Lau MC, Haruki K, Väyrynen JP, Gurjao C, Väyrynen SA, Dias Costa A, Borowsky J, Fujiyoshi K, Arima K, Hamada T, Lennerz JK, Fuchs CS, Nishihara R, Chan AT, ... ... Giannakis M, et al. Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data. Npj Precision Oncology. 7: 57. PMID 37301916 DOI: 10.1038/s41698-023-00406-8 |
0.301 |
|
| 2023 |
Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SH, Qu C, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Aglago EK, Berndt SI, Brenner H, Campbell PT, ... ... Giannakis M, et al. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. Medrxiv : the Preprint Server For Health Sciences. PMID 37090539 DOI: 10.1101/2023.03.10.23287127 |
0.366 |
|
| 2023 |
Ugai T, Haruki K, Harrison TA, Cao Y, Qu C, Chan AT, Campbell PT, Akimoto N, Berndt S, Brenner H, Buchanan DD, Chang-Claude J, Fujiyoshi K, Gallinger SJ, Gunter MJ, ... ... Giannakis M, et al. Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases. The American Journal of Gastroenterology. PMID 36707929 DOI: 10.14309/ajg.0000000000002171 |
0.326 |
|
| 2023 |
Tian J, Chen JH, Chao SX, Pelka K, Giannakis M, Hess J, Burke K, Jorgji V, Sindurakar P, Braverman J, Mehta A, Oka T, Huang M, Lieb D, Spurrell M, et al. Combined PD-1, BRAF and MEK inhibition in BRAF colorectal cancer: a phase 2 trial. Nature Medicine. PMID 36702949 DOI: 10.1038/s41591-022-02181-8 |
0.302 |
|
| 2023 |
Ugai T, Akimoto N, Haruki K, Harrison TA, Cao Y, Qu C, Chan AT, Campbell PT, Berndt SI, Buchanan DD, Cross AJ, Diergaarde B, Gallinger SJ, Gunter MJ, Harlid S, ... ... Giannakis M, et al. Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases. Journal of Gastroenterology. PMID 36648535 DOI: 10.1007/s00535-023-01955-2 |
0.363 |
|
| 2022 |
Yang K, Cao Y, Gurjao C, Liu Y, Guo CG, Lo CH, Zong X, Drew D, Geraghty C, Prezioso E, Moore M, Williams C, Riley T, Saul M, Ogino S, ... Giannakis M, et al. Clinical and Genomic Characterization of Interval Colorectal Cancer in Three Prospective Cohorts. Gastroenterology. PMID 35970241 DOI: 10.1053/j.gastro.2022.08.020 |
0.323 |
|
| 2022 |
Barfield R, Qu C, Steinfelder RS, Zeng C, Harrison TA, Brezina S, Buchanan DD, Campbell PT, Casey G, Gallinger S, Giannakis M, Gruber SB, Gsur A, Hsu L, Huyghe JR, et al. Association between germline variants and somatic mutations in colorectal cancer. Scientific Reports. 12: 10207. PMID 35715570 DOI: 10.1038/s41598-022-14408-2 |
0.336 |
|
| 2022 |
Fang L, Ford-Roshon D, Russo M, O'Brien C, Xiong X, Gurjao C, Grandclaudon M, Raghavan S, Corsello SM, Carr SA, Udeshi ND, Berstler J, Sicinska E, Ng K, Giannakis M. RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition. Nature Communications. 13: 3181. PMID 35676246 DOI: 10.1038/s41467-022-30794-7 |
0.324 |
|
| 2022 |
Georgeson P, Harrison TA, Pope BJ, Zaidi SH, Qu C, Steinfelder RS, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Amitay EL, Berndt SI, Brenner H, Campbell PT, ... ... Giannakis M, et al. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures. Nature Communications. 13: 3254. PMID 35668106 DOI: 10.1038/s41467-022-30916-1 |
0.372 |
|
| 2022 |
Akimoto N, Väyrynen JP, Zhao M, Ugai T, Fujiyoshi K, Borowsky J, Zhong R, Haruki K, Arima K, Lau MC, Kishikawa J, Twombly TS, Takashima Y, Song M, Zhang X, ... ... Giannakis M, et al. Desmoplastic Reaction, Immune Cell Response, and Prognosis in Colorectal Cancer. Frontiers in Immunology. 13: 840198. PMID 35392092 DOI: 10.3389/fimmu.2022.840198 |
0.33 |
|
| 2022 |
Harlid S, Van Guelpen B, Qu C, Gylling B, Aglago EK, Amitay EL, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Drew DA, Figueiredo JC, French AJ, ... ... Giannakis M, et al. Diabetes mellitus in relation to colorectal tumor molecular subtypes - a pooled analysis of more than 9,000 cases. International Journal of Cancer. PMID 35383926 DOI: 10.1002/ijc.34015 |
0.34 |
|
| 2022 |
Ugai T, Haruki K, Väyrynen JP, Borowsky J, Fujiyoshi K, Lau MC, Akimoto N, Zhong R, Kishikawa J, Arima K, Shi SS, Zhao M, Fuchs CS, Zhang X, Giannakis M, et al. Coffee Intake of Colorectal Cancer Patients and Prognosis According to Histopathologic Lymphocytic Reaction and T-Cell Infiltrates. Mayo Clinic Proceedings. 97: 124-133. PMID 34996545 DOI: 10.1016/j.mayocp.2021.09.007 |
0.323 |
|
| 2021 |
Kim M, Ly SH, Xie Y, Duronio GN, Ford-Roshon D, Hwang JH, Sulahian R, Rennhack JP, So J, Gjoerup O, Talamas JA, Grandclaudon M, Long HW, Doench JG, Sethi NS, ... Giannakis M, et al. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis. Developmental Cell. PMID 34990589 DOI: 10.1016/j.devcel.2021.12.006 |
0.307 |
|
| 2021 |
Väyrynen JP, Haruki K, Lau MC, Väyrynen SA, Ugai T, Akimoto N, Zhong R, Zhao M, Dias Costa A, Borowsky J, Bell P, Takashima Y, Fujiyoshi K, Arima K, Kishikawa J, ... ... Giannakis M, et al. Spatial organization and prognostic significance of NK and NKT-like cells via multimarker analysis of the colorectal cancer microenvironment. Cancer Immunology Research. PMID 34937729 DOI: 10.1158/2326-6066.CIR-21-0772 |
0.31 |
|
| 2021 |
Chen B, Scurrah CR, McKinley ET, Simmons AJ, Ramirez-Solano MA, Zhu X, Markham NO, Heiser CN, Vega PN, Rolong A, Kim H, Sheng Q, Drewes JL, Zhou Y, Southard-Smith AN, ... ... Giannakis M, et al. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. Cell. PMID 34910928 DOI: 10.1016/j.cell.2021.11.031 |
0.376 |
|
| 2021 |
Pelka K, Hofree M, Chen JH, Sarkizova S, Pirl JD, Jorgji V, Bejnood A, Dionne D, Ge WH, Xu KH, Chao SX, Zollinger DR, Lieb DJ, Reeves JW, Fuhrman CA, ... ... Giannakis M, et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. PMID 34450029 DOI: 10.1016/j.cell.2021.08.003 |
0.313 |
|
| 2021 |
Gurjao C, Zhong R, Haruki K, Li YY, Spurr LF, Lee-Six H, Reardon B, Ugai T, Zhang X, Cherniack AD, Song M, Van Allen EM, Meyerhardt JA, Nowak JA, Giovannucci EL, ... ... Giannakis M, et al. Discovery and features of an alkylating signature in colorectal cancer. Cancer Discovery. PMID 34140290 DOI: 10.1158/2159-8290.CD-20-1656 |
0.339 |
|
| 2021 |
Adib E, Nassar AH, Akl EW, Abou Alaiwi S, Nuzzo PV, Mouhieddine TH, Sonpavde G, Haddad RI, Mouw KW, Giannakis M, Hodi FS, Shukla SA, Gusev A, Braun DA, Choueiri TK, et al. Alterations and Response to Immunotherapy in Solid Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34074656 DOI: 10.1158/1078-0432.CCR-21-0575 |
0.314 |
|
| 2021 |
Väyrynen JP, Haruki K, Väyrynen SA, Lau MC, Dias Costa A, Borowsky J, Zhao M, Ugai T, Kishikawa J, Akimoto N, Zhong R, Shi S, Chang TW, Fujiyoshi K, Arima K, ... ... Giannakis M, et al. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment. Journal For Immunotherapy of Cancer. 9. PMID 33931472 DOI: 10.1136/jitc-2020-002297 |
0.349 |
|
| 2020 |
Ugai T, Haruki K, Väyrynen JP, Zhong R, Borowsky J, Fujiyoshi K, Lau MC, Zhao M, Akimoto N, Chang TW, Kishikawa J, Arima K, Shi SS, Gu S, Fuchs CS, ... ... Giannakis M, et al. Coffee Intake and Colorectal Cancer Incidence According to T-Cell Response. Jnci Cancer Spectrum. 4: pkaa068. PMID 33409450 DOI: 10.1093/Jncics/Pkaa068 |
0.406 |
|
| 2020 |
Fujiyoshi K, Chen Y, Haruki K, Ugai T, Kishikawa J, Hamada T, Liu L, Arima K, Borowsky J, Väyrynen JP, Zhao M, Lau MC, Gu S, Shi S, Akimoto N, ... ... Giannakis M, et al. Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction. Jnci Cancer Spectrum. 4: pkaa040. PMID 32923934 DOI: 10.1093/Jncics/Pkaa040 |
0.423 |
|
| 2020 |
Hidaka A, Harrison TA, Cao Y, Sakoda LC, Barfield R, Giannakis M, Song M, Phipps AI, Figueiredo JC, Zaidi SH, Toland AE, Amitay EL, Berndt SI, Borozan I, Chan AT, et al. Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies. Cancer Research. PMID 32816852 DOI: 10.1158/0008-5472.Can-20-0168 |
0.39 |
|
| 2020 |
Hinze L, Labrosse R, Degar J, Han T, Schatoff EM, Schreek S, Karim S, McGuckin C, Sacher JR, Wagner F, Stanulla M, Yuan C, Sicinska E, Giannakis M, Ng K, et al. Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy. Cancer Discovery. PMID 32703769 DOI: 10.1158/2159-8290.Cd-19-1472 |
0.359 |
|
| 2020 |
Zaidi SH, Harrison TA, Phipps AI, Steinfelder R, Trinh QM, Qu C, Banbury BL, Georgeson P, Grasso CS, Giannakis M, Adams JB, Alwers E, Amitay EL, Barfield RT, Berndt SI, et al. Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. Nature Communications. 11: 3644. PMID 32686686 DOI: 10.1038/S41467-020-17386-Z |
0.429 |
|
| 2020 |
Fujiyoshi K, Väyrynen JP, Borowsky J, Papke DJ, Arima K, Haruki K, Kishikawa J, Akimoto N, Ugai T, Lau MC, Gu S, Shi S, Zhao M, Da Silva AFL, Twombly TS, ... ... Giannakis M, et al. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer. Ebiomedicine. 57: 102860. PMID 32652320 DOI: 10.1016/J.Ebiom.2020.102860 |
0.363 |
|
| 2020 |
Väyrynen JP, Lau MC, Haruki K, Väyrynen SA, Dias Costa A, Borowsky J, Zhao M, Fujiyoshi K, Arima K, Twombly TS, Kishikawa J, Gu S, Aminmozaffari S, Shi S, Baba Y, ... ... Giannakis M, et al. Prognostic significance of immune cell populations identified by machine learning in colorectal cancer using routine hematoxylin & eosin stained sections. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32439699 DOI: 10.1158/1078-0432.Ccr-20-0071 |
0.453 |
|
| 2020 |
Abou Alaiwi S, Nassar AH, Xie W, Bakouny Z, Berchuck JE, Braun DA, Baca SC, Nuzzo PV, Flippot R, Mouhieddine TH, Spurr LF, Li YY, Li T, Flaifel A, Steinharter JA, ... ... Giannakis M, et al. Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors. Cancer Immunology Research. PMID 32321774 DOI: 10.1158/2326-6066.Cir-19-0866 |
0.418 |
|
| 2020 |
Arima K, Lau MC, Zhao M, Haruki K, Kosumi K, Mima K, Gu M, Väyrynen JP, Twombly TS, Baba Y, Fujiyoshi K, Kishikawa J, Guo C, Baba H, Richards WG, ... ... Giannakis M, et al. Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer. Molecular Cancer Research : McR. PMID 32165453 DOI: 10.1158/1541-7786.Mcr-19-1091 |
0.321 |
|
| 2020 |
Rendo V, Stoimenov I, Mateus A, Sjöberg E, Svensson R, Gustavsson AL, Johansson L, Ng A, OʼBrien C, Giannakis M, Artursson P, Nygren P, Cheong I, Sjöblom T. Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. Nature Communications. 11: 1308. PMID 32161261 DOI: 10.1038/S41467-020-15111-4 |
0.447 |
|
| 2020 |
Haruki K, Kosumi K, Li P, Arima K, Väyrynen JP, Lau MC, Twombly TS, Hamada T, Glickman JN, Fujiyoshi K, Chen Y, Du C, Guo C, Väyrynen SA, Dias Costa A, ... ... Giannakis M, et al. An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer. British Journal of Cancer. PMID 32157241 DOI: 10.1038/S41416-020-0780-3 |
0.397 |
|
| 2020 |
Pleguezuelos-Manzano C, Puschhof J, Huber AR, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, Paganelli FL, Geurts MH, Beumer J, Mizutani T, van der Linden R, ... ... Giannakis M, et al. Mutational signature in colorectal cancer caused by genotoxic pks E. coli. Nature. PMID 32106218 DOI: 10.1038/S41586-020-2080-8 |
0.401 |
|
| 2020 |
Wei XX, McGregor BA, Lee RJ, Gao X, Kilbridge KL, Preston MA, Mossanen M, Ingham MD, Steele GS, Klein A, Allen EMV, Severgnini M, Giannakis M, Sonpavde G. Durvalumab as neoadjuvant therapy for muscle-invasive bladder cancer: Preliminary results from the Bladder Cancer Signal Seeking Trial (BLASST)-2. Journal of Clinical Oncology. 38: 507-507. DOI: 10.1200/Jco.2020.38.6_Suppl.507 |
0.342 |
|
| 2020 |
Jakubowski C, Collins NB, Sugar EA, Berg M, Cao H, Giannakis M, Jaffee EM, Azad NS. A phase I/II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in MSS colorectal cancer. Journal of Clinical Oncology. 38: TPS4114-TPS4114. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps4114 |
0.421 |
|
| 2019 |
Haruki K, Kosumi K, Hamada T, Twombly TS, Väyrynen JP, Kim SA, Masugi Y, Qian ZR, Mima K, Baba Y, da Silva A, Borowsky J, Arima K, Fujiyoshi K, Lau MC, ... ... Giannakis M, et al. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. The Journal of Pathology. PMID 31880318 DOI: 10.1002/Path.5381 |
0.393 |
|
| 2019 |
Shi Y, Liu L, Hamada T, Nowak JA, Giannakis M, Ma Y, Song M, Nevo D, Kosumi K, Gu M, Kim SA, Morikawa T, Wu K, Sui J, Papantoniou K, et al. Night-shift work duration and risk of colorectal cancer according to IRS1 and IRS2 expression. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31666286 DOI: 10.1158/1055-9965.Epi-19-0325 |
0.327 |
|
| 2019 |
Li H, Bullock K, Gurjao C, Braun D, Shukla SA, Bossé D, Lalani AA, Gopal S, Jin C, Horak C, Wind-Rotolo M, Signoretti S, McDermott DF, Freeman GJ, Van Allen EM, ... ... Giannakis M, et al. Metabolomic adaptations and correlates of survival to immune checkpoint blockade. Nature Communications. 10: 4346. PMID 31554815 DOI: 10.1038/S41467-019-12361-9 |
0.348 |
|
| 2019 |
Gurjao C, Liu D, Hofree M, AlDubayan SH, Wakiro I, Su MJ, Felt K, Gjini E, Brais LK, Rotem A, Rosenthal MH, Rozenblatt-Rosen O, Rodig S, Ng K, Van Allen EM, ... ... Giannakis M, et al. Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair Deficient Colorectal Cancer. Cancer Immunology Research. PMID 31217164 DOI: 10.1158/2326-6066.Cir-18-0683 |
0.474 |
|
| 2019 |
Li H, Ning S, Ghandi M, Kryukov GV, Gopal S, Deik A, Souza A, Pierce K, Keskula P, Hernandez D, Ann J, Shkoza D, Apfel V, Zou Y, Vazquez F, ... ... Giannakis M, et al. The landscape of cancer cell line metabolism. Nature Medicine. 25: 850-860. PMID 31068703 DOI: 10.1038/S41591-019-0404-8 |
0.423 |
|
| 2019 |
Chan EM, Shibue T, McFarland JM, Gaeta B, Ghandi M, Dumont N, Gonzalez A, McPartlan JS, Li T, Zhang Y, Bin Liu J, Lazaro JB, Gu P, Piett CG, Apffel A, ... ... Giannakis M, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. PMID 30971823 DOI: 10.1038/S41586-019-1102-X |
0.359 |
|
| 2019 |
Hamada T, Yuan C, Yurgelun MB, Perez K, Khalaf N, Morales-Oyarvide V, Babic A, Nowak JA, Rubinson DA, Giannakis M, Ng K, Kraft P, Stampfer MJ, Giovannucci EL, Fuchs CS, et al. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. British Journal of Cancer. PMID 30867564 DOI: 10.1038/S41416-019-0426-5 |
0.383 |
|
| 2019 |
Kosumi K, Hamada T, Zhang S, Liu L, da Silva A, Koh H, Twombly TS, Mima K, Morikawa T, Song M, Nowak JA, Nishihara R, Saltz LB, Niedzwiecki D, Ou FS, ... ... Giannakis M, et al. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. European Journal of Cancer (Oxford, England : 1990). 111: 82-93. PMID 30826660 DOI: 10.1016/J.Ejca.2019.01.022 |
0.406 |
|
| 2019 |
Yang W, Liu L, Keum N, Qian ZR, Nowak JA, Hamada T, Song M, Cao Y, Nosho K, Smith-Warner SA, Zhang S, Masugi Y, Ng K, Kosumi K, Ma Y, ... ... Giannakis M, et al. Calcium intake and risk of colorectal cancer according to tumor infiltrating T cells. Cancer Prevention Research (Philadelphia, Pa.). PMID 30760501 DOI: 10.1158/1940-6207.Capr-18-0279 |
0.386 |
|
| 2019 |
Tripathi A, Xie W, Flaifel A, Steinharter JA, Stern Gatof E, Jennings RB, Bouchard G, Fleischer J, Chanza NM, Gray C, Mantia C, Wei XX, Giannakis M, McGregor BA, Choueiri TK, et al. Prognostic significance of CD73 expression in localized renal cell carcinoma (RCC). Journal of Clinical Oncology. 37: 4582-4582. DOI: 10.1200/Jco.2019.37.15_Suppl.4582 |
0.313 |
|
| 2019 |
Zaidi S, Phipps A, Harrison T, Grasso C, Steinfelder R, Trinh Q, Connolly C, Banbury B, Rafikova A, Hofer P, Brezina S, Giannakis M, Mu XJ, Quist M, Fuchs C, et al. Abstract 1224: Deep targeted tumor sequencing of colorectal cancer cases to study associations of molecular subtypes with clinical, genetic, and lifestyle risk factors Cancer Research. 78: 1224-1224. DOI: 10.1158/1538-7445.Am2018-1224 |
0.474 |
|
| 2019 |
Keller RB, Mazor T, Giannakis M, Nowak J, Sholl L, Aguirre A, Bass A, Sethi N, Nagaraja A, Brais L, Reilly E, Cerami E, Wolpin B. Abstract C130: Precision oncology decision support within the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute (GI TARGET) Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C130 |
0.402 |
|
| 2018 |
Koh H, Hamada T, Song M, Liu L, Cao Y, Nowak JA, da Silva A, Twombly T, Morikawa T, Kim SA, Masugi Y, Kosumi K, Shi Y, Gu M, Li W, ... ... Giannakis M, et al. Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells. Jnci Cancer Spectrum. 2: pky058. PMID 31276098 DOI: 10.1093/Jncics/Pky058 |
0.417 |
|
| 2018 |
Wasserman I, Lee LH, Ogino S, Marco MR, Wu C, Chen X, Datta J, Sadot E, Szeglin B, Guillem J, Paty PB, Weiser MR, Nash GM, Saltz L, Barlas A, ... ... Giannakis M, et al. SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30587545 DOI: 10.1158/1078-0432.Ccr-18-1726 |
0.43 |
|
| 2018 |
Grasso CS, Giannakis M. Genomic mechanisms of immune evasion in colorectal cancer: from discovery to clinical practice. Oncotarget. 9: 33743-33744. PMID 30333906 DOI: 10.18632/Oncotarget.26105 |
0.4 |
|
| 2018 |
Hamada T, Nowak JA, Masugi Y, Drew DA, Song M, Cao Y, Kosumi K, Mima K, Twombly TS, Liu L, Shi Y, da Silva A, Gu M, Li W, Nosho K, ... ... Giannakis M, et al. Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells. Journal of the National Cancer Institute. PMID 30312431 DOI: 10.1093/Jnci/Djy137 |
0.382 |
|
| 2018 |
Kosumi K, Hamada T, Koh H, Borowsky J, Bullman S, Twombly TS, Nevo D, Masugi Y, Liu L, da Silva A, Chen Y, Du C, Gu M, Li C, Li W, ... ... Giannakis M, et al. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. The American Journal of Pathology. PMID 30243655 DOI: 10.1016/J.Ajpath.2018.08.015 |
0.484 |
|
| 2018 |
Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, ... ... Giannakis M, et al. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunology Research. PMID 30228205 DOI: 10.1158/2326-6066.Cir-18-0174 |
0.418 |
|
| 2018 |
Hamada T, Liu L, Nowak JA, Mima K, Cao Y, Ng K, Twombly TS, Song M, Jung S, Dou R, Masugi Y, Kosumi K, Shi Y, da Silva A, Gu M, ... ... Giannakis M, et al. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. European Journal of Cancer (Oxford, England : 1990). 103: 98-107. PMID 30219720 DOI: 10.1016/J.Ejca.2018.07.130 |
0.329 |
|
| 2018 |
Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, ... ... Giannakis M, et al. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. Oncoimmunology. 7: e1442999. PMID 29900052 DOI: 10.1080/2162402X.2018.1442999 |
0.458 |
|
| 2018 |
Ogino S, Giannakis M. Immunoscore for (colorectal) cancer precision medicine. Lancet (London, England). PMID 29754776 DOI: 10.1016/S0140-6736(18)30953-X |
0.417 |
|
| 2018 |
Liu L, Tabung FK, Zhang X, Nowak JA, Qian ZR, Hamada T, Nevo D, Bullman S, Mima K, Kosumi K, da Silva A, Song M, Cao Y, Twombly TS, Shi Y, ... ... Giannakis M, et al. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 29702299 DOI: 10.1016/J.Cgh.2018.04.030 |
0.349 |
|
| 2018 |
Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, Morikawa T, Nosho K, Abril-Rodriguez G, Connolly C, Escuin-Ordinas H, et al. Genetic mechanisms of immune evasion in colorectal cancer. Cancer Discovery. PMID 29510987 DOI: 10.1158/2159-8290.Cd-17-1327 |
0.475 |
|
| 2018 |
AlDubayan SH, Giannakis M, Moore ND, Han GC, Reardon B, Hamada T, Mu XJ, Nishihara R, Qian Z, Liu L, Yurgelun MB, Syngal S, Garraway LA, Ogino S, Fuchs CS, et al. Inherited DNA-Repair Defects in Colorectal Cancer. American Journal of Human Genetics. PMID 29478780 DOI: 10.1016/J.Ajhg.2018.01.018 |
0.434 |
|
| 2018 |
Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA, Giovannucci EL, Nishihara R, Giannakis M, Garrett WS, Song M. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. PMID 29437869 DOI: 10.1136/Gutjnl-2017-315537 |
0.372 |
|
| 2018 |
Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, Norton C, Bossé D, Wankowicz SM, Cullen D, Horak C, Wind-Rotolo M, Tracy A, Giannakis M, Hodi FS, et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science (New York, N.Y.). PMID 29301960 DOI: 10.1126/Science.Aan5951 |
0.385 |
|
| 2018 |
Perez K, Weekes CD, Cleary JM, Abrams TA, Blaszkowsky LS, Enzinger PC, Giannakis M, Goyal L, Meyerhardt JA, Rubinson DA, Yurgelun MB, Stonely D, Raghavan S, Bakir B, Das K, et al. Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer. Journal of Clinical Oncology. 36: 693-693. DOI: 10.1200/Jco.2020.38.4_Suppl.693 |
0.318 |
|
| 2018 |
Tripathi A, Johnston SE, Zhao YD, Hassan O, Thompson LF, Lalani AA, Wei XX, Giannakis M, Signoretti S, Choueiri TK, Harshman LC. CD73 expression in primary and metastatic renal cell carcinoma (RCC). Journal of Clinical Oncology. 36: 643-643. DOI: 10.1200/Jco.2018.36.6_Suppl.643 |
0.313 |
|
| 2018 |
Giannakis M, Grasso C, Wells D, Hamada T, Mu XJ, Quist M, Nowak J, Nishihara R, Connolly CM, Shukla S, Grady WM, Wheeler D, Wu CJ, Zaretsky J, Garraway L, et al. Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-Pr03 |
0.507 |
|
| 2018 |
Rodon J, Argilés G, Connolly RM, Vaishampayan U, Jonge Md, Garralda E, Giannakis M, Smith DC, Dobson JR, McLaughlin M, Seroutou A, Ji Y, Dolan S, Morawiak J, Moody S, et al. Abstract CT175: Biomarker analyses from a phase I study of WNT974, a first-in-class Porcupine inhibitor, in patients (pts) with advanced solid tumors Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct175 |
0.44 |
|
| 2018 |
Yang W, Liu L, Keum N, Qian ZR, Nowak JA, Hamada T, Song M, Cao Y, Nosho K, Smith-Warner SA, Zhang S, Masugi Y, Ng K, Kosumi K, Ma Y, ... ... Giannakis M, et al. Abstract 693: Calcium intake and risk of colorectal cancer according to tumor-infiltrating T cells: Results from two large U.S. prospective cohorts Cancer Research. 78: 693-693. DOI: 10.1158/1538-7445.Am2018-693 |
0.422 |
|
| 2018 |
Luo J, Giannakis M, Colditz G, Wang J, Chapman W, Toriola AT, Mito Y, Nishihara R, Nowak J, Fuchs C, Giovannucci E, Chan AT, Bass A, Ogino S, Fields R, et al. Abstract 1228: Comparative genomic analysis of young-onset and late-onset colorectal cancer Cancer Research. 78: 1228-1228. DOI: 10.1158/1538-7445.Am2018-1228 |
0.387 |
|
| 2018 |
Grasso C, Giannakis M, Wells D, Wheeler D, Shinbrot E, Zaidi S, Huyghe J, Geybels M, Salipante S, Abril-Rodriguez G, Escuin-Ordinas H, Puig-Saus C, Shin DS, Ogino S, Ribas A, et al. Abstract B011: Immunoediting in untreated mismatch repair deficient colorectal cancer Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B011 |
0.487 |
|
| 2017 |
Gu M, Nishihara R, Chen Y, Li W, Shi Y, Masugi Y, Hamada T, Kosumi K, Liu L, da Silva A, Nowak JA, Twombly T, Du C, Koh H, Li W, ... ... Giannakis M, et al. Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells. Oncotarget. 8: 87379-87389. PMID 29152088 DOI: 10.18632/Oncotarget.20972 |
0.403 |
|
| 2017 |
Masugi Y, Nishihara R, Hamada T, Song M, da Silva A, Kosumi K, Gu M, Shi Y, Li W, Liu L, Nevo D, Inamura K, Cao Y, Liao X, Nosho K, ... ... Giannakis M, et al. Tumor PDCD1LG2 (PD-L2) expression and the lymphocytic reaction to colorectal cancer. Cancer Immunology Research. PMID 29038297 DOI: 10.1158/2326-6066.Cir-17-0122 |
0.414 |
|
| 2017 |
Zhang X, Choi PS, Francis JM, Gao GF, Campbell JD, Ramachandran A, Mitsuishi Y, Ha G, Shih J, Vazquez F, Tsherniak A, Taylor AM, Zhou J, Wu Z, Berger AC, ... Giannakis M, et al. Somatic super-enhancer duplications and hotspot mutations lead to oncogenic activation of the KLF5 transcription factor. Cancer Discovery. PMID 28963353 DOI: 10.1158/2159-8290.Cd-17-0532 |
0.456 |
|
| 2017 |
Hamada T, Cao Y, Qian ZR, Masugi Y, Nowak JA, Yang J, Song M, Mima K, Kosumi K, Liu L, Shi Y, da Silva A, Gu M, Li W, Keum N, ... ... Giannakis M, et al. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016707547. PMID 28406723 DOI: 10.1200/Jco.2016.70.7547 |
0.444 |
|
| 2017 |
Giannakis M, Ng K. To Treat or Not to Treat: Adjuvant Therapy for Stage II Colon Cancer in the Era of Precision Oncology. Journal of Oncology Practice. 13: 242-244. PMID 28399380 DOI: 10.1200/Jop.2017.022103 |
0.317 |
|
| 2017 |
Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, et al. Precancer Atlas to Drive Precision Prevention Trials. Cancer Research. 77: 1510-1541. PMID 28373404 DOI: 10.1158/0008-5472.Can-16-2346 |
0.435 |
|
| 2017 |
Ghazani AA, Oliver NM, St Pierre JP, Garofalo A, Rainville IR, Hiller E, Treacy DJ, Rojas-Rudilla V, Wood S, Bair E, Parello M, Huang F, Giannakis M, Wilson FH, Stover EH, et al. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 28125075 DOI: 10.1038/Gim.2016.191 |
0.345 |
|
| 2017 |
Rohanizadegan M, Aldubayan SH, Giannakis M, Mu XJ, Nishihara R, Qian ZR, Nowak J, Cao Y, Liu L, Song M, Chan AT, Garraway LA, Ogino S, Fuchs CS, Van Allen EM. Clinical actionability of germline testing in patients with limited colorectal polyps. Journal of Clinical Oncology. 35: e13027-e13027. DOI: 10.1200/Jco.2017.35.15_Suppl.E13027 |
0.409 |
|
| 2017 |
Giannakis M, Li H, Jin C, Gopal S, Desai K, Horak C, Wind-Rotolo M, Van Allen EM, Clish C, Hodi FS, Garraway LA, Choueiri TK. Metabolomic correlates of response in nivolumab-treated renal cell carcinoma and melanoma patients. Journal of Clinical Oncology. 35: 3036-3036. DOI: 10.1200/Jco.2017.35.15_Suppl.3036 |
0.315 |
|
| 2017 |
Aldubayan SH, Giannakis M, Moore N, Mu XJ, Han GC, Nishihara R, Qian ZR, Liu L, Ogino S, Garraway LA, Fuchs CS, Van Allen EM. Enrichment of germline DNA-repair gene mutations in patients with colorectal cancer. Journal of Clinical Oncology. 35: 1500-1500. DOI: 10.1200/Jco.2017.35.15_Suppl.1500 |
0.407 |
|
| 2017 |
Nishihara R, Chan AT, Mu JX, Giannakis M, Mima K, Qian ZR, Bullman S, Kostic AD, Huttenhower C, Garrett W, Giovannucci EL, Meyerson M, Garraway LA, Fuchs CS, Ogino S. Abstract PR01:Fusobacterium nucleatumand mutational landscape of colorectal cancer in whole-exome sequencing analysis Cancer Research. 77. DOI: 10.1158/1538-7445.Crc16-Pr01 |
0.426 |
|
| 2017 |
Mima K, Hamada T, Nishihara R, Nowak J, Qian ZR, Kosumi K, Giannakis M, Bullman S, Baba H, Huttenhower C, Garrett W, Chan A, Meyerson M, Fuchs C, Ogino S. Abstract 4560: Fusobacterium nucleatum and tumor immunity status according to microsatellite instability in colorectal cancer Cancer Research. 77: 4560-4560. DOI: 10.1158/1538-7445.Am2017-4560 |
0.461 |
|
| 2017 |
Zaidi SH, Sun W, Huyghe J, Grasso CS, Trinh Q, Connolly C, French A, Mu J, Giannakis M, Shinbrot E, Borozan I, Quist MJ, Brenner H, Buchanan D, Campbell P, et al. Abstract 1286: Targeted deep sequencing of colorectal tumor tissues to study associations of tumor subtypes with germline genetic, lifestyle, and environmental risk factors Epidemiology. 77: 1286-1286. DOI: 10.1158/1538-7445.Am2017-1286 |
0.358 |
|
| 2016 |
Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, Li W, Hamada T, Kosumi K, Hanyuda A, Liu L, ... ... Giannakis M, et al. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clinical and Translational Gastroenterology. 7: e200. PMID 27811909 DOI: 10.1038/Ctg.2016.53 |
0.378 |
|
| 2016 |
Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Reports. 17: 1206. PMID 27760322 DOI: 10.1016/J.Celrep.2016.10.009 |
0.362 |
|
| 2016 |
Garofalo A, Sholl L, Reardon B, Taylor-Weiner A, Amin-Mansour A, Miao D, Liu D, Oliver N, MacConaill L, Ducar M, Rojas-Rudilla V, Giannakis M, Ghazani A, Gray S, Janne P, et al. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Genome Medicine. 8: 79. PMID 27460824 DOI: 10.1186/S13073-016-0333-9 |
0.376 |
|
| 2016 |
Gibson WJ, Hoivik EA, Halle MK, Taylor-Weiner A, Cherniack AD, Berg A, Holst F, Zack TI, Werner HM, Staby KM, Rosenberg M, Stefansson IM, Kusonmano K, Chevalier A, Mauland KK, ... ... Giannakis M, et al. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. Nature Genetics. PMID 27348297 DOI: 10.1038/Ng.3602 |
0.453 |
|
| 2016 |
Masugi Y, Nishihara R, Yang J, Mima K, da Silva A, Shi Y, Inamura K, Cao Y, Song M, Nowak JA, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, et al. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut. PMID 27196573 DOI: 10.1136/Gutjnl-2016-311421 |
0.346 |
|
| 2016 |
Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, Sukawa Y, Stewart C, Rosenberg M, Mima K, Inamura K, et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Reports. PMID 27149842 DOI: 10.1016/J.Celrep.2016.03.075 |
0.489 |
|
| 2016 |
Giannakis M, Mu JX, Shukla S, Qian ZR, Cohen O, Nishihara R, Cao Y, Yamauchi M, Sukawa Y, Nosho K, Ng K, Meyerhardt JA, Lawrence M, Gabriel SB, Lander E, et al. Novel driver genes and genomic predictors of immune infiltrates in colorectal cancer. Journal of Clinical Oncology. 34: 557-557. DOI: 10.1200/Jco.2016.34.4_Suppl.557 |
0.47 |
|
| 2016 |
Zaidi SH, Grasso C, Mu J, Shinbrot E, Giannakis M, Connolly C, Borozan I, Brenner H, Campbell P, Chan A, Chang-Claude J, Du M, Ferretti V, French A, Fuchs C, et al. Abstract 5221: Linking the molecular profile of colorectal tumors to germline genetic and environmental risk factors Cancer Research. 76: 5221-5221. DOI: 10.1158/1538-7445.Am2016-5221 |
0.453 |
|
| 2016 |
Grasso CS, Shinbrot E, Yu M, Liesersen M, Chaisson M, Chan A, Connolly C, Dai J, Du M, Fuchs C, Garraway L, Giannakis M, Harrison T, Hsu L, Huyghe J, et al. Abstract 136: Refining the molecular profile of colorectal tumors to expand prevention and treatment opportunities Cancer Research. 76: 136-136. DOI: 10.1158/1538-7445.Am2016-136 |
0.444 |
|
| 2015 |
Mima K, Nishihara R, Nowak J, Kim SA, Song M, Inamura K, Sukawa Y, Masuda A, Yang J, Dou R, Nosho K, Baba H, Giovannucci EL, Bowden M, Loda M, ... Giannakis M, et al. MicroRNA MIR21 and T-cells in Colorectal Cancer. Cancer Immunology Research. PMID 26419959 DOI: 10.1158/2326-6066.Cir-15-0084 |
0.361 |
|
| 2015 |
Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. PMID 26311717 DOI: 10.1136/Gutjnl-2015-310101 |
0.401 |
|
| 2015 |
Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. Jama Oncology. PMID 26181352 DOI: 10.1001/Jamaoncol.2015.1377 |
0.421 |
|
| 2015 |
Van Allen EM, Golay HG, Liu Y, Koyama S, Wong K, Taylor-Weiner A, Giannakis M, Harden M, Rojas-Rudilla V, Chevalier A, Thai T, Lydon C, Mach S, Avila AG, Wong JA, et al. Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation. Cancer Immunology Research. PMID 26014096 DOI: 10.1158/2326-6066.Cir-15-0024 |
0.349 |
|
| 2015 |
Giannakis M, Shukla S, Mu JX, Nishihara R, Yamauchi M, Sukawa Y, Qian ZR, Nosho K, Inamura K, Bahl S, Ng K, Chan AT, Meyerhardt JA, Gabriel SB, Lander E, et al. Comprehensive molecular characterization of colorectal cancer reveals genomic predictors of immune cell infiltrates. Journal of Clinical Oncology. 33: 3505-3505. DOI: 10.1200/Jco.2015.33.15_Suppl.3505 |
0.466 |
|
| 2014 |
Giannakis M, Hodis E, Jasmine Mu X, Yamauchi M, Rosenbluh J, Cibulskis K, Saksena G, Lawrence MS, Qian ZR, Nishihara R, Van Allen EM, Hahn WC, Gabriel SB, Lander ES, Getz G, et al. RNF43 is frequently mutated in colorectal and endometrial cancers. Nature Genetics. 46: 1264-6. PMID 25344691 DOI: 10.1038/Ng.3127 |
0.416 |
|
| 2009 |
Giannakis M, Bäckhed HK, Chen SL, Faith JJ, Wu M, Guruge JL, Engstrand L, Gordon JI. Response of gastric epithelial progenitors to Helicobacter pylori Isolates obtained from Swedish patients with chronic atrophic gastritis. The Journal of Biological Chemistry. 284: 30383-94. PMID 19723631 DOI: 10.1074/Jbc.M109.052738 |
0.478 |
|
| 2008 |
Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 4358-63. PMID 18332421 DOI: 10.1073/Pnas.0800668105 |
0.536 |
|
| 2006 |
Oh JD, Kling-Bäckhed H, Giannakis M, Xu J, Fulton RS, Fulton LA, Cordum HS, Wang C, Elliott G, Edwards J, Mardis ER, Engstrand LG, Gordon JI. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proceedings of the National Academy of Sciences of the United States of America. 103: 9999-10004. PMID 16788065 DOI: 10.1073/Pnas.0603784103 |
0.517 |
|
| 2006 |
Giannakis M, Stappenbeck TS, Mills JC, Leip DG, Lovett M, Clifton SW, Ippolito JE, Glasscock JI, Arumugam M, Brent MR, Gordon JI. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. The Journal of Biological Chemistry. 281: 11292-300. PMID 16464855 DOI: 10.1074/Jbc.M512118200 |
0.662 |
|
| 2006 |
Oh JD, Kling-Bäckhed H, Giannakis M, Engstrand LG, Gordon JI. Interactions between gastric epithelial stem cells and Helicobacter pylori in the setting of chronic atrophic gastritis. Current Opinion in Microbiology. 9: 21-7. PMID 16406776 DOI: 10.1016/J.Mib.2005.12.013 |
0.494 |
|
| Show low-probability matches. |